Friends holding benefit to help Totowa woman pay for cancer care NorthJersey.com BY MATTHEW KADOSH TOTOWA - Less than 1 percent of people develop a malignant brain or spinal cord tumor, according to the American Cancer Society. Unfortunately, 44-year-old Wendy Bove is among that 1 percent. Wendy Bove, 44, has been fighting brain ...
New Medication to Reduce Bone Complications Now Available in Ontario - DigitalJournal.com (press release)
New Medication to Reduce Bone Complications Now Available in Ontario DigitalJournal.com (press release) When cancer metastasizes to the bone, a number of serious complications can occur. These may include broken bones, spinal cord compression, as well as the need for radiation and/or surgery to the bone. In people with advanced prostate cancer, ...
Fighting Brain Cancer: Taking out more than tumors - WFTV Orlando
Fighting Brain Cancer: Taking out more than tumors WFTV Orlando BACKGROUND: Glioma is a broad term of brain and spinal cord tumors that comes from glial cells. Glial cells are the main brain cells that can develop into cancer. The symptoms, prognosis, and treatment of a malignant glioma can vary depending on the ...
Amgen Receives Complete Response Letter From FDA for XGEVAŽ sBLA for ... - MarketWatch (press release)
Amgen Receives Complete Response Letter From FDA for XGEVAŽ sBLA for ... MarketWatch (press release) XGEVA has been approved in Mexico for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in patients with advanced malignancies involving bone. In Japan, Amgen is working ...
QualityStocks News - European Medicines Agency Awards Arno Therapeutics AR-42 ... - Virtual-Strategy Magazine
QualityStocks News - European Medicines Agency Awards Arno Therapeutics AR-42 ... Virtual-Strategy Magazine QualityStocks would like to highlight Arno Therapeutics, a publicly traded clinical-stage biopharmaceutical company developing innovative products for the treatment of cancer. Arno has exclusive worldwide rights to develop and market three innovative ...
Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe - SunHerald.com
Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe SunHerald.com NF2 is a rare genetic disorder characterized by the growth of noncancerous tumors in the brain and spinal cord, juvenile cataracts and neurofibromas of the skin. The disease is caused by mutations in a gene which plays a role in preventing cells from ...
Pet health: Are muscle spasms in dogs a sign of a more serious problem? Newsolio (blog) This toxin then prevents the release of inhibitory neurotransmitters in the brain and spinal cord, causing the muscles to spasm and contract until they become rigid. Tetanus often contracts the facial muscles and causes the jaw to become rigid (hence ...
Boy miraculously survives brain cancer - Covington News
Boy miraculously survives brain cancer Covington News "It interferes with the cable system that carries all the information to the brain to the spinal cord and the information from the spinal cord up into the brain." Astrocytomas are nearly always deadly, because as they grow they interfere with more and ...
Brain Tumor Vaccine Shows Promise - Cancer Network
Brain Tumor Vaccine Shows Promise Cancer Network Glioblastoma multiforme is the most prevalent type of primary malignant brain tumor. It is associated with a poor prognosis?the 5-year survival rate is approximately 4.5%. Overall, more than 22000 malignant brain and spinal cord tumors were diagnosed ...
Arno gains orphan-drug status for AR-42 in Europe - Pharmaceutical Business Review
Arno gains orphan-drug status for AR-42 in Europe Pharmaceutical Business Review AR-42 is currently being studied in a Phase I/IIa trial with relapsed or refractory hematologic malignancies patients and solid tumour patients. NF2 is a genetic disorder characterized by the growth of noncancerous tumours in the brain and spinal cord, ...
What our clients and candidates are saying about us: Thanks Tim - you’re definitely one of the few good recruiters out there and I really appreciate all your efforts and help. - Rana
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.